innorna

CN

NEWSROOM

ALL Press Release Awards Media Center

Press Release

2023. 02. 25

Innorna’s SARS-CoV-2 mRNA vaccine received FDA clearance for Phase I clincial trial

Awards

2023. 02. 02

Innorna ranked on 2022 Vigorous 100 List

Awards

2023. 01. 11

2022 VENTURE Sprouts List and 2022 PEdaily Healthcare VENTURE50

Press Release

2022. 12. 20

Innorna’s Covid mRNA Vaccine Approved by New Zealand for Phase I Clinical Trial

Awards

2022. 12. 02

WISE 2022 King of the New Economy-Enterprise of the Year - 36Kr

Awards

2022. 09. 16

China New Technology Pharmaceutical Innovative Enterprises Top 30

Awards

2022. 08. 23

Hurun China Cheetahs 2022 Half-Year Report

Awards

2022. 07. 29

MIT Technology Review - 2021 TR50

Press Release

2022. 07. 06

Innorna and BeiGene Announce Strategic Research Collaboration to Jointly Discover Novel mRNA Therapies

Awards

2022. 06. 16

2022 Future Healthcare 100 - Top 100 Innovative Biomedicine Companies

Awards

2022. 05. 26

China Healthcare Consulting

Press Release

2022. 03. 28

Innorna raises USD 120 million in Series B funding

010203

innorna

TEL

+86 (0755) 8653 3681

+852 3520 2228


EMAIL

info@innorna.com

info.hk@innorna.com


ADDRESS

Shenzhen Office: 6/F, Tower B, Tsinghua Information Port, 1 Songping Mountain New East Road, Nanshan, Shenzhen

Hong Kong Office: Rm 222, 12 W Science and Technology West Avenue, Phase 3, HKSTP, Shatin, HKSAR

Nanjing Office: 5/F, Tower B, Phase 1, Zhongdan Eco-Life Science Industrial Park, Pukou, Nanjing

  • TECHNOLOGY
  • PIPELINE
  • ACHIEVEMENTS
  • ABOUT Innorna
  • INVESTORS AND PARTNERSHIP
  • NEWSROOM
  • JOIN US
  • CONTACT US

© 2023 Innorna Co. Ltd. ALL RIGHTS REVERSED

粤ICP备2020110996号
Design by sumaart